Association of thyroid stimulating hormone and coronary lipid risk factors with lipid peroxidation in hypothyroidism

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 5, 2008, Pages 674-679

  Nanda, Nivedita ^a   Bobby, Zachariah ^a   Hamide, Abdoul ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Coronary lipid risk factors; Hypothyroidism; Malondialdehyde; Thyroid stimulating hormone

Indexed keywords

CYTOKINE; GLUTATHIONE; MALONALDEHYDE; THYROTROPIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY RISK; CYTOKINE RELEASE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPOTHYROIDISM; INDIA; LIPID PEROXIDATION; MALE; MYOCARDIAL DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; THYROTROPIN BLOOD LEVEL;

ADOLESCENT; ADULT; BODY MASS INDEX; CORONARY DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPOTHYROIDISM; LIPID PEROXIDATION; LIPIDS; MALE; MIDDLE AGED; RISK FACTORS; THYROTROPIN;

EID: 44349159082     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.139     Document Type: Article

References (38)

1. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol 1995;43:55-68.
2. Vanderpump MP, Tunbridge WM. The epidemiology of thyroid disease. In: Braverman LE, Utiger RD, editors. The thyroid, 9th ed. Philadelphia, PA: Lippencott-Raven, 1996:474-82.
3. Biondi B, Fazio S, Palmieri EA, Carella C, Panza N, Cittadini A, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999;84:2064-7.
4. Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C, et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab 2001;86:1110-5.
5. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-8.
6. Foubert L, Dejager S, Bruckert E, Turpin G. Lipid risk factors of atherosclerosis: who, when, how to treat? Ann Endocrinol 1997;58:275-82.
7. Nivedita N, Zachariah B, Abdoul H, Koner BC, Sridhar MG. Association of oxidative stress and coronary lipid risk factors in hypothyroidism is independent of body mass index. Metabolism 2007;56:1350-5.
8. O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993;68:860-6.
9. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metabol 2003;88:2438-44.
10. Karinsky NI. Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 1992;200:248-54.
11. Yesilbursa D, Serdar J, Serdar A, Sarac M, Coskun S, Jale C. Lipid peroxides in obese patients and effects of weight loss with orlistat on lipid peroxides levels. Int J Obes 2005;29:142-5.
12. Sutken E, Inal M, Ozdemir F. Effects of vitamin E and gemfibrozil on lipid profiles, lipid peroxidation and antioxidant status in the elderly and young hyperlipidemic subjects. Saudi Med J 2006;27:453-9.
13. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-8.
14. Ogita H, Liao J. Endothelial function and oxidative stress. Endothelium 2004;11:123-32.
15. Olinescu R, Radaceanu V, Nita S, Lupeanu E. Age dependent variations of the plasma peroxides and total antioxidants in women with obesity and hypothyroidism. Rom J Intern Med 1992;30:285-90.
16. Sundaram V, Hanna Atef N, Koneru L, Newman H, Falko JM. Both hypothyroidism and hyperthyroidism enhance low-density lipoprotein oxidation. J Clin Endocrinol Metab 1997;82:3421-4.
17. Dardano A, Ghiadoni L, Plantinga Y, Caraccio N, Bemi A, Duranti E, et al. Recombinant human TSH reduces endothelium dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006;91:4175-8.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
19. Ridker MD, Rifai N, Cook NR, Bradwin G, Buring JE. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures and CRP as risk factors in women. J Am Med Assoc 2005;294:326-33.
20. Grover SA, Coupal L, Hu XP. Identifying adults at increased risk of coronary artery disease. J Am Med Assoc 1995;274:801-6.
21. Wallach J. Interpretation of laboratory tests, 6th ed. Boston, MA: Little Brown and Co, 1996:482 pp.
22. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Burtis CA, Ashwood ER, editors. Tietz textbook of clinical chemistry, 3rd ed. Philadelphia, USA: WB Saunders Company, 1999:1653.
23. Wendel A. Glutathione peroxidase. Methods Enzymol 1981;105:325-33.
24. Habig WM, Pabst MJ, Jakoby WB. Glutathione S transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-9.
25. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
26. Satoh K. Serum lipid peroxide in cardiovascular disease, determined by a new colorimetric method. Clin Chim Acta 1978;90:37-43.
27. Levine RL, William J, Stadtman ER, Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346-57.
28. Dumitriu L, Bartoc R, Ursu H, Purice M, Ionescu V. Significance of high levels of serum TBARS (MDA) and ceruloplasmin (CP) in hyper and hypothyroidism. Endocrinologie 1988;26;35-8.
29. Baskol G, Atmaca H, Tanrverdi F, Baskol M, Kocer D, Bayram F. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism. Exp Clin Endocrinol Diabetes 2007;115:522-6.
30. Buettner GR. The packing order of free radicals and antioxidants: lipid peroxidation, α-tocopherol and ascorbate. Arch Biochem Biophys 1993;300:535-43.
31. Porter NA. Chemistry of lipid peroxidation. Methods Enzymol 1984;105:273-82.
32. Slater TF. Free radical mechanism in tissue injury. Biochem J 1984;222:1-15.
33. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329:23-38.
34. Lu D, Maulik N, Maru II, Kreutzer DL, Das DK. Molecular adaptation of vascular endothelial cells to oxidative stress. Am J Physiol 1993;264:C715-22.
35. Hayes J, Stranger R. Potential contribution of the glutathione S transferase supergene family to resistance to oxidative stress. Free Radic Res 1995;22:193-207.
36. Kershaw EF, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrine Metab 2004;89:2548-56.
37. Coutlier JP, Kehrl JH, Bellur SS, Kohn LD, Notkins AL, Prabhakar BS. Binding and functional effects of thyroid stimulating hormone on human immune cells. J Clin Immunol 1990;10:204-10.
38. Donnini D, Ambesi-Impiombato FS, Curcio F. Thyroid stimulating hormone stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells. Thyroid 2003;13:517-21.